AMRX

AMRX

USD

Amneal Pharmaceuticals Inc. Class A Common Stock

$11.350+0.340 (3.088%)

リアルタイム価格

Healthcare
Drug Manufacturers - Specialty & Generic
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$11.010

高値

$11.400

安値

$10.940

出来高

3.47M

企業ファンダメンタルズ

時価総額

3.6B

業種

Drug Manufacturers - Specialty & Generic

United States

取引統計

平均出来高

1.66M

取引所

NMS

通貨

USD

52週レンジ

安値 $6.685現在値 $11.350高値 $11.4

関連ニュース

Analyst Upgrades

Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13

Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.

もっと見る
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
GlobeNewswire

Amneal Reports Third Quarter 2025 Financial Results

‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,

もっと見る
Amneal Reports Third Quarter 2025 Financial Results
GlobeNewswire

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's

もっと見る